Skip to content

Peter A. Goldstein

2 papers in the library · 6 citations · publishing 2022-2025

Papers

Sort Most recent Most cited

551. PSYCHEDELICS AND OCD: TRANSLATIONAL APPROACHES

The International Journal of Neuropsychopharmacology August 1, 2025 Bernard Lerer, Michal Brownstien, Mitchell A. Lazar et al.

Abstract Background Obsessive-compulsive disorder (OCD) is associated with significant personal suffering and functional impairment. At least a third of OCD patients do not respond to conventional treatments. There is a substantial anecdotal literature suggesting that psychedelic agents, specifically psilocybin and psilocybin-containing psychedelic mushroom extract (PME), may be therapeutic in...

Targeting Affective Mood Disorders With Ketamine to Prevent Chronic Postsurgical Pain.

Front Pain Res (Lausanne) June 27, 2022 Dianna E. Willis, Peter A. Goldstein 6 citations

The phencyclidine-derivative ketamine [2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one] was added to the World Health Organization's Model List of Essential Medicines in 1985 and is also on the Model List of Essential Medicines for Children due to its efficacy and safety as an intravenous anesthetic. In sub-anesthetic doses, ketamine is an effective analgesic for the treatment of acute pain...